Insider · CIK 0001686997
John Pye
officer
Files at EXPO (EXPONENT INC). First filing May 23, 2025, latest May 23, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $153k sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
EXPO: EXPONENT INC
EXPOOct 9, 2026 · close 69.81
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 41Moderate | EXPONENT INC | $153k 2,000 shares | -6% | +2% from low-33% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 23, 2025 | EXPO EXPONENT INC | SOpen-market sale Common Stock | -342 | $76.34 | $26k | 30,862 | May 23, 2025 |
| May 23, 2025 | EXPO EXPONENT INC | SOpen-market sale Common Stock | -1,658 | $76.32 | $127k | 29,204 | May 23, 2025 |
| Mar 14, 2025 | EXPO EXPONENT INC | AGrant or award Restricted Stock Unitsderivative | +6,286 | - | - | 6,286 | Mar 17, 2025 |
| Mar 12, 2025 | EXPO EXPONENT INC | MOption exercise Common Stock | +3,438 | - | - | 32,070 | Mar 14, 2025 |
| Mar 12, 2025 | EXPO EXPONENT INC | FTax withholding Common Stock | -866 | $82.33 | $71k | 31,204 | Mar 14, 2025 |
| Mar 12, 2025 | EXPO EXPONENT INC | MOption exercise Restricted Stock Unitsderivative | -3,438 | - | - | 0 | Mar 14, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.